Trial intelligence / Profile preview

The MANTRA Trial: Post-operative Antibiotics Following Surgery for Mandible Fractures

NCT05964140Phase 3Recruiting

Sponsor
East Lancashire Hospitals NHS Trust
Start
Dec 2024
Primary completion
Jun 2027
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of amoxicillin + clavulanate in Mandible fracture (3 arms), sponsored by East Lancashire Hospitals NHS Trust. Primary endpoint: Surgical Site Infection at 30 days. Started Dec 2024; status: recruiting.

02

Drugs

amoxicillin + clavulanate
03

Conditions

Mandible fracture

Beyond the preview

Go deeper on NCT05964140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05964140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call